Ceyhan Taşkin, Günay Volkan, Capoğlu Ahmet, Sayrak Hakan, Karaca Cetin
Ozel Cevre Hastanesi Ortopedi ve Travmatoloji Bölümü.
Acta Orthop Traumatol Turc. 2007 Aug-Oct;41(4):307-13.
Glass-ceramics are biomaterials that are usually produced by the sol-gel technique and can be used as a substitute for bone. One important feature of glass-ceramics is osteointegration with bone tissue. This study was designed to produce a glass-ceramic and evaluate its structure and in vitro and in vivo biological effects.
With the sol-gel method, a glass-ceramic was synthesized in the form of 30SiO2-17MgO-53Ca3(PO4)2 using tetraethylorthosilicate, dibutyl phosphate, magnesium, and calcium nitrate. Glass-ceramic jel samples were sintered at temperatures up to 1100 degrees C and their microstructure and phases were examined by the X-ray diffraction (XRD) technique and scanning electron microscopy. For in vitro tests, the samples were immersed in a simulative body fluid (SBF) for 10, 30, and 40 days to be analyzed by XRD. For in vivo tests, the samples were placed in tibial metaphyses of Sprague-Dawley rats for 4, 6, and 8 weeks for histological evaluation of osteointegration.
As the temperature increased, growth of crystal phases was noted. While XRD analysis showed no change in samples that were kept in SBF for 10 days, hydroxyapatite crystals were seen after 30 and 40 days of SBF treatment in the second and third degree of crystal phases. In vivo test results showed that the glass-ceramic possessed a high tendency to replace osteoid bone tissue, with full osteointegration at eight weeks.
The glass-ceramic produced has a high surface reactivity and can be used as a bone substitute material.
微晶玻璃是通常采用溶胶 - 凝胶技术生产的生物材料,可作为骨替代物。微晶玻璃的一个重要特性是与骨组织的骨整合。本研究旨在制备一种微晶玻璃,并评估其结构以及体外和体内生物学效应。
采用溶胶 - 凝胶法,以正硅酸乙酯、磷酸二丁酯、镁和硝酸钙为原料,合成了30SiO₂ - 17MgO - 53Ca₃(PO₄)₂形式的微晶玻璃。将微晶玻璃凝胶样品在高达1100℃的温度下烧结,通过X射线衍射(XRD)技术和扫描电子显微镜检查其微观结构和相。对于体外测试,将样品浸入模拟体液(SBF)中10、30和40天,然后通过XRD进行分析。对于体内测试,将样品置于Sprague - Dawley大鼠的胫骨近端干骺端4、6和8周,以进行骨整合的组织学评估。
随着温度升高,观察到晶相生长。虽然XRD分析显示在SBF中保存10天的样品没有变化,但在SBF处理30天和40天后,在第二和第三晶相中观察到羟基磷灰石晶体。体内测试结果表明,微晶玻璃具有很高的替代类骨质骨组织的倾向,在8周时实现完全骨整合。
所制备的微晶玻璃具有高表面反应性,可作为骨替代材料使用。